Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative analysis of dose volume histogram reduction algorithms for normal tissue complication probability

L Cozzi1, F M Buffa, A Fogliata

  • 1Radio-Oncology Department, Ospedale S. Giovanni, Bellinzona, Switzerland. lucozzi@pobox.cscs.ch

Acta Oncologica (Stockholm, Sweden)
|June 20, 2000
PubMed
Summary

Estimating normal tissue complication probability (NTCP) using dose volume histogram (DVH) reduction requires careful consideration. Different DVH reduction methods show significant variations in sensitivity to dose homogeneity and model parameters, impacting radiotherapy treatment planning.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant Hypofractionated Whole Breast Irradiation (WBI) vs. Accelerated Partial Breast Irradiation (APBI) in Postmenopausal Women with Early Stage Breast Cancer: 5Years Update of the HYPAB Trial.

Clinical breast cancer·2024
Same author

The pattern of failure after Stereotactic Radiation Therapy (SRT) for oligo-metastases: predictive factors for poly-progression.

Journal of cancer research and clinical oncology·2022
Same author

Radiogenomic analysis of primary breast cancer reveals [18F]-fluorodeoxglucose dynamic flux-constants are positively associated with immune pathways and outperform static uptake measures in associating with glucose metabolism.

Breast cancer research : BCR·2022
Same author

Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2021
Same author

The Clean Care Contest: promoting hand hygiene among healthcare and medical students.

Annali di igiene : medicina preventiva e di comunita·2020
Same author

The impact of scanning data measurements on the Acuros dose calculation algorithm configuration.

Radiation oncology (London, England)·2020

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Biostatistics

Background:

  • Accurate normal tissue complication estimation (NTCP) is crucial for optimizing radiotherapy.
  • The Lyman-Kutcher-Burman model is widely used for NTCP calculations.
  • Dose volume histogram (DVH) reduction algorithms are employed to simplify DVH data for NTCP models.

Purpose of the Study:

  • To analyze the reliability and internal consistency of popular DVH reduction algorithms applied to the Lyman model for NTCP calculation.
  • To compare the performance of five different DVH reduction methods.
  • To investigate the sensitivity of these methods to model parameters, dose bin size, and dose inhomogeneities.

Main Methods:

  • Analysis of five distinct DVH reduction algorithms applied to the Lyman model.

Related Experiment Videos

  • Comparison of algorithms using parameter sets for varied dose-response relationships.
  • Assessment of sensitivity to dose inhomogeneities using representative DVHs from radiation therapy routines.

    • Main Results:

    • Significant differences were observed between DVH reduction methods concerning their sensitivity to irradiation homogeneity, model parameters, and DVH dose bin size.
    • Structural aspects of the reduction formalism were identified as key to explaining these observed differences.
    • The study highlights the delicate nature of DVH reduction for NTCP calculations.

    Conclusions:

    • DVH reduction for NTCP calculation is a complex field requiring extreme caution in clinical applications.
    • Current DVH reduction formulations need further tuning against robust clinical data.
    • Careful selection and validation of DVH reduction methods are essential for reliable radiotherapy treatment planning.